Time to initial glycopeptide therapy and 30-day mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
Abstract Background The optimal time cut-off for appropriate antibiotic therapy (AAT) in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia remains uncertain. We assessed the effects of time to AAT on 30-day in-hospital mortality in patients with MRSA bacteremia who received glycopeptides...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2025-11-01
|
| Serija: | BMC Infectious Diseases |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s12879-025-12040-9 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|